Gamble Jones Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.07M | Hold |
9,683
| – | – | 0.08% | 109 |
|
|
2022
Q3 | $834K | Sell |
9,683
-384
| -4% | -$34.3K | 0.07% | 117 |
|
|
2022
Q2 | $918K | Sell |
10,067
-1,400
| -12% | -$124K | 0.07% | 115 |
|
|
2022
Q1 | $941K | Sell |
11,467
-1,332
| -10% | -$105K | 0.06% | 122 |
|
|
2021
Q4 | $981K | Hold |
12,799
| – | – | 0.06% | 121 |
|
|
2021
Q3 | $961K | Sell |
12,799
-900
| -7% | -$68.4K | 0.06% | 121 |
|
|
2021
Q2 | $1.06M | Sell |
13,699
-925
| -6% | -$68.8K | 0.07% | 116 |
|
|
2021
Q1 | $1.08M | Sell |
14,624
-1,523
| -9% | -$112K | 0.07% | 119 |
|
|
2020
Q4 | $1.26M | Sell |
16,147
-652
| -4% | -$49.9K | 0.09% | 111 |
|
|
2020
Q3 | $1.33M | Sell |
16,799
-995
| -6% | -$77.9K | 0.1% | 100 |
|
|
2020
Q2 | $1.31M | Sell |
17,794
-534
| -3% | -$40.2K | 0.11% | 96 |
|
|
2020
Q1 | $1.35M | Sell |
18,328
-367
| -2% | -$28.8K | 0.12% | 92 |
|
|
2019
Q4 | $1.62M | Buy |
18,695
+22
| +0.1% | +$1.81K | 0.13% | 97 |
|
|
2019
Q3 | $1.5M | Sell |
18,673
-783
| -4% | -$62.8K | 0.12% | 103 |
|
|
2019
Q2 | $1.56M | Sell |
19,456
-378
| -2% | -$28.9K | 0.13% | 98 |
|
|
2019
Q1 | $1.57M | Sell |
19,834
-135
| -0.7% | -$10.1K | 0.14% | 97 |
|
|
2018
Q4 | $1.46M | Hold |
19,969
| – | – | 0.15% | 97 |
|
|
2018
Q3 | $1.35M | Sell |
19,969
-548
| -3% | -$34.9K | 0.13% | 109 |
|
|
2018
Q2 | $1.19M | Sell |
20,517
-786
| -4% | -$44.3K | 0.12% | 109 |
|
|
2018
Q1 | $1.11M | Sell |
21,303
-349
| -2% | -$18.8K | 0.11% | 119 |
|
|
2017
Q4 | $1.16M | Buy |
21,652
+2
| +0% | +$111 | 0.11% | 113 |
|
|
2017
Q3 | $1.32M | Sell |
21,650
-640
| -3% | -$38.8K | 0.14% | 109 |
|
|
2017
Q2 | $1.36M | Sell |
22,290
-1,627
| -7% | -$99K | 0.14% | 109 |
|
|
2017
Q1 | $1.45M | Sell |
23,917
-900
| -4% | -$54.6K | 0.15% | 110 |
|
|
2016
Q4 | $1.39M | Sell |
24,817
-1,030
| -4% | -$60.3K | 0.15% | 104 |
|
|
2016
Q3 | $1.54M | Buy |
25,847
+236
| +0.9% | +$13.8K | 0.17% | 98 |
|
|
2016
Q2 | $1.41M | Buy |
25,611
+1,597
| +7% | +$85K | 0.15% | 100 |
|
|
2016
Q1 | $1.21M | Buy |
24,014
+2,091
| +10% | +$102K | 0.13% | 106 |
|
|
2015
Q4 | $1.1M | Sell |
21,923
-407
| -2% | -$20.5K | 0.12% | 110 |
|
|
2015
Q3 | $1.05M | Sell |
22,330
-645
| -3% | -$34.3K | 0.12% | 117 |
|
|
2015
Q2 | $1.25M | Sell |
22,975
-66
| -0.3% | -$3.7K | 0.13% | 116 |
|
|
2015
Q1 | $1.26M | Buy |
23,041
+200
| +0.9% | +$11.3K | 0.13% | 115 |
|
|
2014
Q4 | $1.24M | Sell |
22,841
-288
| -1% | -$16K | 0.13% | 114 |
|
|
2014
Q3 | $1.31M | Sell |
23,129
-104
| -0.4% | -$5.84K | 0.14% | 106 |
|
|
2014
Q2 | $1.28M | Sell |
23,233
-180
| -0.8% | -$9.82K | 0.14% | 108 |
|
|
2014
Q1 | $1.27M | Buy |
23,413
+316
| +1% | +$16.4K | 0.15% | 102 |
|
|
2013
Q4 | $1.1M | Sell |
23,097
-208
| -0.9% | -$9.51K | 0.13% | 113 |
|
|
2013
Q3 | $1.06M | Sell |
23,305
-3,847
| -14% | -$176K | 0.14% | 107 |
|
|
2013
Q2 | $1.2M | Buy |
+27,152
| New | +$1.21M | 0.16% | 98 |
|
Other funds holding MRK
AWA
Gamble Jones Investment Counsel's MRK Position: Q4 2022 in Review
Gamble Jones Investment Counsel held its Merck (MRK) position steady in Q4 2022 at 9,683 shares worth $1.07M. The position accounts for 0.08% of the portfolio, ranked #109.
Gamble Jones Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.62M in Q4 2019. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Gamble Jones Investment Counsel held 9,683 shares of Merck worth $1.07M as of Q4 2022.
- Gamble Jones Investment Counsel left its Merck share count unchanged in Q4 2022.
- Merck made up 0.08% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #109 holding.
- Gamble Jones Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Merck position peaked at $1.62M in Q4 2019.
- 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.